Rikke S. Møller

21.1k total citations
121 papers, 2.4k citations indexed

About

Rikke S. Møller is a scholar working on Genetics, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Rikke S. Møller has authored 121 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Genetics, 44 papers in Molecular Biology and 43 papers in Psychiatry and Mental health. Recurrent topics in Rikke S. Møller's work include Genetics and Neurodevelopmental Disorders (54 papers), Epilepsy research and treatment (43 papers) and Genomics and Rare Diseases (37 papers). Rikke S. Møller is often cited by papers focused on Genetics and Neurodevelopmental Disorders (54 papers), Epilepsy research and treatment (43 papers) and Genomics and Rare Diseases (37 papers). Rikke S. Møller collaborates with scholars based in Denmark, Germany and United States. Rikke S. Møller's co-authors include Elena Gardella, Niels Tommerup, Allan Bayat, Guido Rubboli, Helle Hjalgrim, Katrine M. Johannesen, Reinhard Ullmann, Ingo Helbig, Zeynep Tümer and Dennis Lal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Rikke S. Møller

114 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rikke S. Møller Denmark 28 1.3k 1.0k 792 426 316 121 2.4k
Sarah Weckhuysen Belgium 26 860 0.7× 1.0k 1.0× 961 1.2× 584 1.4× 339 1.1× 71 2.3k
Dennis Lal United States 26 945 0.7× 916 0.9× 477 0.6× 315 0.7× 151 0.5× 79 1.9k
Eiji Nakagawa Japan 25 550 0.4× 900 0.9× 682 0.9× 547 1.3× 376 1.2× 177 2.6k
Xinhua Bao China 24 864 0.7× 1.1k 1.0× 388 0.5× 363 0.9× 148 0.5× 130 2.0k
Giulia Barcia France 17 501 0.4× 583 0.6× 539 0.7× 292 0.7× 221 0.7× 56 1.3k
M J During United States 22 436 0.3× 1.0k 1.0× 489 0.6× 1.1k 2.7× 151 0.5× 28 2.1k
Stéphanie Schorge United Kingdom 29 525 0.4× 1.8k 1.7× 629 0.8× 1.6k 3.8× 266 0.8× 67 3.0k
Leanne M. Dibbens Australia 38 2.1k 1.6× 2.2k 2.1× 2.5k 3.2× 1.8k 4.1× 588 1.9× 73 4.9k
Wangzhen Shen United States 26 451 0.3× 916 0.9× 467 0.6× 820 1.9× 66 0.2× 51 1.5k
Jasper J. Anink Netherlands 30 331 0.3× 1.1k 1.0× 457 0.6× 657 1.5× 206 0.7× 68 2.5k

Countries citing papers authored by Rikke S. Møller

Since Specialization
Citations

This map shows the geographic impact of Rikke S. Møller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rikke S. Møller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rikke S. Møller more than expected).

Fields of papers citing papers by Rikke S. Møller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rikke S. Møller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rikke S. Møller. The network helps show where Rikke S. Møller may publish in the future.

Co-authorship network of co-authors of Rikke S. Møller

This figure shows the co-authorship network connecting the top 25 collaborators of Rikke S. Møller. A scholar is included among the top collaborators of Rikke S. Møller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rikke S. Møller. Rikke S. Møller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Oudin, Madeleine J., Francesca Furia, Cecilie Johannessen Landmark, et al.. (2025). Cenobamate as add‐on treatment for SCN8A developmental and epileptic encephalopathy. Epilepsia. 66(4). 1119–1128. 7 indexed citations
3.
Nicolai, Joost, Elisabeth A. Cats, Gerhard Kluger, et al.. (2025). Amitriptyline use in individuals with KCNQ2/3 gain‐of‐function variants: A retrospective cohort study. Epilepsia. 66(5). 1628–1640. 2 indexed citations
4.
Kaufman, Michael C., Shridhar Parthasarathy, Julie Xian, et al.. (2025). Deciphering the Natural History of SCN8A -Related Disorders. Neurology. 104(9). e213533–e213533. 1 indexed citations
5.
Khinchi, Marianne Søndergaard, María J. Miranda, Trine Bjørg Hammer, et al.. (2024). Seizure and movement disorder in CACNA1E developmental and epileptic encephalopathy: Two sides of the same coin or same side of two different coins?. Epileptic Disorders. 26(4). 520–526.
6.
Ortigoza‐Escobar, Juan Darío, et al.. (2024). Emergence of lingual dystonia and strabismus in early‐onset SCN8A self‐limiting familial infantile epilepsy. Epileptic Disorders. 26(2). 219–224.
7.
8.
Fenger, Christina, Marjolaine Willems, Ángel Aledo‐Serrano, et al.. (2023). Intrafamilial variability in SLC6A1-related neurodevelopmental disorders. Frontiers in Neuroscience. 17. 1219262–1219262. 8 indexed citations
9.
Pérez‐Palma, Eduardo, Tobias Brünger, Konrad Platzer, et al.. (2023). CNV-ClinViewer: enhancing the clinical interpretation of large copy-number variants online. Bioinformatics. 39(5). 8 indexed citations
10.
Ahring, Philip K., Angelo Keramidas, Vivian W. Y. Liao, et al.. (2023). Correlations of receptor desensitization of gain-of-function GABRB3 variants with clinical severity. Brain. 147(1). 224–239. 3 indexed citations
11.
Johannesen, Katrine M., Jimmi Nielsen, Anne Sabers, et al.. (2023). The phenotypic presentation of adult individuals with SLC6A1-related neurodevelopmental disorders. Frontiers in Neuroscience. 17. 1216653–1216653. 4 indexed citations
12.
Hjortshøj, Tina Duelund, Morten Dunø, Lotte Risom, et al.. (2023). DNA methylation signature classification of rare disorders using publicly available methylation data. Clinical Genetics. 103(6). 688–692. 1 indexed citations
13.
Gardella, Elena, Roberto Michelucci, Christina Fenger, et al.. (2023). IRF2BPL as a novel causative gene for progressive myoclonus epilepsy. Epilepsia. 64(8). e170–e176. 5 indexed citations
14.
Grimmel, Mona, Darius Ebrahimi‐Fakhari, Angelika Rieß, et al.. (2022). Expansion of the phenotypic and molecular spectrum of CWF19L1 ‐related disorder. Clinical Genetics. 103(5). 566–573. 2 indexed citations
15.
Bayat, Allan, Manuela Pendziwiat, Ewa Obersztyn, et al.. (2021). Deep-Phenotyping the Less Severe Spectrum of PIGT Deficiency and Linking the Gene to Myoclonic Atonic Seizures. Frontiers in Genetics. 12. 663643–663643. 7 indexed citations
16.
Schönewolf‐Greulich, Bitten, Alexandra Afenjar, Magalie Barth, et al.. (2021). Clinical and molecular delineation of PUS3 ‐associated neurodevelopmental disorders. Clinical Genetics. 100(5). 628–633. 26 indexed citations
17.
Heinrich, Ronit, Tali Garin-Shkolnik, Tova Hershkovitz, et al.. (2021). Two de novo GluN2B mutations affect multiple NMDAR-functions and instigate severe pediatric encephalopathy. eLife. 10. 12 indexed citations
18.
Schröter, Julian, Saskia Biskup, Kerstin Alexandra Klotz, et al.. (2021). Refining Genotypes and Phenotypes in KCNA2-Related Neurological Disorders. International Journal of Molecular Sciences. 22(6). 2824–2824. 25 indexed citations
19.
Klitten, Laura L., Rikke S. Møller, Marina Nikanorova, et al.. (2011). A balanced translocation disruptsSYNGAP1in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA). Epilepsia. 52(12). e190–e193. 21 indexed citations
20.
Mefford, Heather C., Séverine Clauin, Andrew J. Sharp, et al.. (2007). Recurrent Reciprocal Genomic Rearrangements of 17q12 Are Associated with Renal Disease, Diabetes, and Epilepsy. The American Journal of Human Genetics. 81(5). 1057–1069. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Weckhuysen Breakdown of academic impact, for papers by Dennis Lal Breakdown of academic impact, for papers by Eiji Nakagawa Breakdown of academic impact, for papers by Xinhua Bao Breakdown of academic impact, for papers by Giulia Barcia Breakdown of academic impact, for papers by M J During Breakdown of academic impact, for papers by Stéphanie Schorge Breakdown of academic impact, for papers by Leanne M. Dibbens Breakdown of academic impact, for papers by Wangzhen Shen Breakdown of academic impact, for papers by Jasper J. Anink
Rankless by CCL
2026